Ellagic acid (EA) is a naturally occurring polyphenolic compound with antioxidant properties found in a variety of fruits and vegetables, including strawberries, raspberries, pomegranates, and nuts such as pecans and walnuts. EA appears to have potential health benefits, but more research is needed to fully understand its effects and mechanisms and how it can be used safely and effectively as a complimentary medicine. Notably, accumulating evidence demonstrates the anti-inflammatory effects of EA, but a unified mechanism is not well understood. A network pharmacology approach was used to understand the anti-inflammatory effects of EA. It was revealed that there are 52 targets of EA that are related to inflammation. GO and KEGG revealed many relevant signaling pathways, diseases relevant to inflammation. Topological analysis determined 10 important targets that are AKT1, VEGFA, TNF, MAPK3, ALB, SELP, MMP9, MMP2, PTGS2, and ICAM1. Molecular docking and molecular dynamics simulations were employed to help determine AKT1, PTGS2, VEGFA, MAPK3 as the most probable targets of EA with molecular mechanics Poisson-Boltzmann surface area binding energies of -82.37, -52.06, -19.24, and -13.98 kJ/mol, respectively. Overall, this paper confirmed the anti-inflammatory effects of EA demonstrated in previous studies and pinpointed very probably targets of EA.